Public Joint-Stock Company "Human Stem Cells Institute"
ISKJ.ME
Price:
$45.74
Market Cap:
$3.73B
Public Joint-Stock Company "Human Stem Cells Institute," identified by the symbol ISKJ.ME, operates primarily as a biotechnology enterprise within Russia. The company focuses on pharmaceutical innovation, encompassing research, development, and the commercialization of its proprietary offerings in various therapeutic areas. These include regenerative medicine, bio-insurance, medical genetics (with a specific emphasis on reproductive applications), gene therapy, and biopharmaceutics. The institute manages Gemabank, a prominent family cord blood stem cell repository serving Russia and the Commonwealth of Independent States (CIS), and Reprobank, a facility for the personal cryopreservation of r...[Read more]
Industry
Biotechnology
IPO Date
2010-03-03
Stock Exchange
MCX
Ticker
ISKJ.ME
PE Ratio
[175.92]
ROE
[6.05%]
Current Ratio
[1.79]
Dividend Yield
[0%]
Enterprise Value
[4.13B]
Dividend History
The PE Ratio as of June 2026 (TTM) for Public Joint-Stock Company "Human Stem Cells Institute" (ISKJ.ME) is 175.92
According to Public Joint-Stock Company "Human Stem Cells Institute"’s latest financial reports and current stock price. The company's current PE Ratio is 175.92. This represents a change of 3.08% compared to the average of 5.53 of the last 4 quarters.
Public Joint-Stock Company "Human Stem Cells Institute" (ISKJ.ME) Historical PE Ratio (quarterly & annually)
How has ISKJ.ME PE Ratio performed in the past?
The mean historical PE Ratio of Public Joint-Stock Company "Human Stem Cells Institute" over the last ten years is 106.44. The current 175.92 PE Ratio has changed 16.43% with respect to the historical average. Over the past ten years (40 quarters), ISKJ.ME's PE Ratio was at its highest in in the December 2020 quarter at 3.43K. The PE Ratio was at its lowest in in the December 2021 quarter at -604.29.
Average
106.44
Median
37.62
Minimum
-17.45
Maximum
790.30
Public Joint-Stock Company "Human Stem Cells Institute" (ISKJ.ME) PE Ratio by Quarter and Year
Discovering the peaks and valleys of Public Joint-Stock Company "Human Stem Cells Institute" PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.91%
Maximum Annual PE Ratio = 790.30
Minimum Annual Increase = -166.02%
Minimum Annual PE Ratio = -17.45
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | 52.20 | 45.40% |
| 2024 | 35.90 | -35.94% |
| 2023 | 56.04 | -52.14% |
| 2022 | 117.09 | -85.18% |
| 2021 | 790.30 | 1.91% |
| 2020 | 39.34 | 241.43% |
| 2019 | 11.52 | -166.02% |
| 2018 | -17.45 | 107.61% |
| 2017 | -8.41 | -30.88% |
| 2016 | -12.16 | -20.03% |
Public Joint-Stock Company "Human Stem Cells Institute" (ISKJ.ME) Average PE Ratio
How has ISKJ.ME PE Ratio performed in the past?
The current PE Ratio of Public Joint-Stock Company "Human Stem Cells Institute" (ISKJ.ME) is greater than its 3-year, less than than its 5-year, and greater than its 10-year historical averages
3-year avg
48.05
5-year avg
210.31
10-year avg
106.44
Public Joint-Stock Company "Human Stem Cells Institute" (ISKJ.ME) PE Ratio vs. Peers
How is ISKJ.ME’s PE Ratio compared to its peers?
Public Joint-Stock Company "Human Stem Cells Institute"’s PE Ratio is
| Company | PE Ratio | Market cap |
|---|
Build a custom stock screener for Public Joint-Stock Company "Human Stem Cells Institute" (ISKJ.ME) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Public Joint-Stock Company "Human Stem Cells Institute" using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Public Joint-Stock Company "Human Stem Cells Institute" (ISKJ.ME) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Public Joint-Stock Company "Human Stem Cells Institute" or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the PE Ratio?
How can you use the PE Ratio?
What is Public Joint-Stock Company "Human Stem Cells Institute"'s PE Ratio?
How is the PE Ratio calculated for Public Joint-Stock Company "Human Stem Cells Institute" (ISKJ.ME)?
What is the highest PE Ratio for Public Joint-Stock Company "Human Stem Cells Institute" (ISKJ.ME)?
What is the 3-year average PE Ratio for Public Joint-Stock Company "Human Stem Cells Institute" (ISKJ.ME)?
What is the 5-year average PE Ratio for Public Joint-Stock Company "Human Stem Cells Institute" (ISKJ.ME)?
How does the current PE Ratio for Public Joint-Stock Company "Human Stem Cells Institute" (ISKJ.ME) compare to its historical average?